Eckert & Ziegler SE (VIE:EUZG)

Austria flag Austria · Delayed Price · Currency is EUR
17.34
-0.14 (-0.80%)
Last updated: Oct 23, 2025, 11:00 AM CET
-0.80%
Market Cap1.10B
Revenue (ttm)299.27M
Net Income (ttm)36.64M
Shares Outn/a
EPS (ttm)0.58
PE Ratio30.15
Forward PE21.71
Dividend0.17 (0.96%)
Ex-Dividend DateJun 19, 2025
Volumen/a
Average Volume66
Open17.53
Previous Close17.48
Day's Range17.34 - 17.53
52-Week Range15.15 - 23.02
Betan/a
RSI50.49
Earnings DateNov 13, 2025

About Eckert & Ziegler SE

Eckert & Ziegler SE manufactures and sells isotope technology components worldwide. It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of prostate cancer seeds; and eye applicators based on ruthenium-106 and iodine-125 for the treatment of uveal melanomas; brain seed, HDR and brachytherapy; ophthalmological products; therapeutic and radiotherapy accessories, X-Ray therapy, GA-68 generators, radiochromatography, hot cells; and radiopharmaceuticals, laboratory equipment, radiosynt... [Read more]

Industry Industrial Inorganic Chemicals
Founded 2024
Employees 1,085
Stock Exchange Vienna Stock Exchange
Ticker Symbol EUZG
Full Company Profile

Financial Performance

In 2024, Eckert & Ziegler SE's revenue was 295.85 million, an increase of 20.22% compared to the previous year's 246.09 million. Earnings were 33.28 million, an increase of 26.52%.

Financial Statements

News

There is no news available yet.